AMPEL BioSolutions reposted this
Co-Founder & President, Precision Health Co, Inflammation Forecast w Abnormal Drug Targets (Lupus, Psoriasis, Eczema, Scleroderma, Nephritis, Cardiology)
CardioGENE measures druggable pathways of inflammation driven by inherited genetic mutations that increase risk for heart attacks & strokes. AMPEL’s Cell iScience paper indicates immune system abnormalities predict #cardiovascular risk even when lipids are in the normal range for both non-autoimmune individuals as well as those with #inflammatory & #autoimmune conditions such as #Lupus, #Psoriasis, Type 1 Diabetes, RA, Primary Biliary Cirrhosis & Celiac/IBD.